British Association for Psychopharmacology (BAP) is a UK-based scientific society that promotes research and education in psychopharmacology—the study of how drugs affect mood, behaviour and mental processes. BAP supports both…
A drug used for Parkinson’s disease has been shown to be effective in reducing the symptoms of difficult to treat depression, in a study led by the University of Oxford….
Recent developments in psychiatry and neuroscience are shedding light on the potential of digital and pharmacological innovations to transform mental health care. Two new significant studies from the University of…
The successful parent-led programme, developed with support from the NIHR Oxford Health Biomedical Research Centre (OH BRC) and the Applied Research Collaboration Oxford and Thames Valley (ARC OxTV), is being…
Statins deemed safe from a neuropsychiatric perspective but ineffective as antidepressants in at-risk adults, Oxford study finds. A landmark online trial published in Psychological Medicine and conducted at the University…
Researchers from Oxford’s two NIHR Biomedical Research Centres (BRC) took over the city’s Westgate Centre on Thursday 29 May for their annual Health Research Showcase. Hundreds of half-term visitors, including…
What happens when the last known habitat for an endangered species stands in the way of vital human development? Last Haven, a study led by researchers at the University of…
The UK government has set an ambitious target to have 10% of the population participating in research by 2025. This initiative aims to enhance public engagement in scientific research, ensuring…
A major new meta-analysis has found that glucagon-like peptide 1 receptor agonists (GLP1- RAs) may also offer benefits for emotional wellbeing. A major new meta-analysis led by the Institute of…
Oxford Health Biomedical Research Centre (OH BRC) is excited to announce an academic opportunity for Nurses, Midwives, and Allied Health Professionals (NMAHPs) connected with organisations in the Buckinghamshire, Oxfordshire and…
A Joint Effort by Oxford Health BRC and the University of Oxford Department of Psychiatry. Mental Health Awareness Week is an annual event that highlights the importance of mental well-being…
A new paper in the Journal of Neurology, Neurosurgery & Psychiatry discusses how GLP-1RAs, drugs approved for diabetes and obesity, may play a role in the treatment of major neurocognitive…
DPhil student in the Department of Psychiatry at Oxford Centre for Human Brain Activity (OHBA) and OH BRC Research Coordinator at Oxford Brain Health Centre (BHC) Jasmine Blane chatted to the Oxford Sparks podcast recently about the work she…
Neurodiversity Week, celebrated recently, was a week-long celebration aimed at raising awareness and promoting understanding of neurodiversity, a concept that acknowledges the naturally occurring variations in human neurocognitive capabilities. Neurodiversity…
The Mental Health Research for Innovation Centre (M-RIC) in Liverpool is one of two National Institute for Health and Care Research (NIHR) Mental Health Translational Research Centre (MH-TRC) Mental Health Mission…
Recently, the Oxford Health Biomedical Research Centre (OH BRC) held its Mid-Term Review in Oxford with our International Advisory Board members, who play a crucial role at OH BRC. The…
In a recent randomised clinical trial it was found that cognitive behavioural therapy for insomnia (CBT-I) did not significantly alter emotional processing of facial expressions following treatment in individuals with clinically…
The UK-French Mental Health Biomarkers Consortium is an international initiative aimed at revolutionising the field of mental health diagnosis and treatment through the identification and validation of biomarkers. This consortium…
The Oxford Brain Health Clinic (OBHC) invited its research participants to an event at Cornerstone Arts Centre, Didcot recently to update them on how their data is providing benefit in…
A paper published today in Nature Mental Health reports on how GLP-1RAs, drugs approved for diabetes and obesity, might be useful for the treatment of cognitive and mental health disorders….